Schlottmann Francisco, Strassle Paula D, Molena Daniela, Patti Marco G
1 Department of Surgery, University of North Carolina School of Medicine , Chapel Hill, North Carolina.
2 Department of Surgery, Hospital Alemán of Buenos Aires, University of Buenos Aires , Buenos Aires, Argentina .
J Laparoendosc Adv Surg Tech A. 2019 Feb;29(2):213-217. doi: 10.1089/lap.2018.0434. Epub 2018 Oct 25.
The indication of surgical resection in esophageal cancer is often conditioned by patient's age. We aimed to assess the trends in utilization of surgical treatment for esophageal adenocarcinoma (EAC) in the United States, stratified by age groups.
We performed a retrospective analysis of the National Cancer Institute's Surveillance, Epidemiology, and End Results program registry for the period 2004-2014. Adult patients (aged ≥18 years) diagnosed with EAC were eligible for inclusion. The yearly incidence of esophagectomy, stratified by age groups (18-49, 50-70, and >70 years old), was calculated using Poisson regression. Weighted log-binomial regression was used to compare the proportion of patients undergoing esophagectomy, within each age group. Inverse probability of treatment weights were used to account for potential confounders.
A total of 21,301 patients were included. During the study period, the rate of esophagectomy decreased from 34.1% to 28.2% (P = .40) in patients between 18 and 49 years old, from 38.6% to 33.3% (P = .06) in patients between 50 and 70 years old, and from 21.4% to 16.9% (P = .04) in patients older than 70 years. After accounting for patient and cancer characteristics, patients older than 70 years were 50% less likely to undergo esophagectomy compared with both patients between 18 and 49 years old (risk ratio [RR] 0.51, 95% confidence interval [CI] 0.45-0.57, P < .0001) and patients between 50 and 70 years old (RR 0.53, 95% CI 0.50-0.56, P < .0001).
Surgical resection is scarcely used in patients older than 70 years in the United States. Further investigation of surgical outcomes in elderly patients is warranted to determine if surgical treatment is underutilized in a large proportion of EAC patients.
食管癌手术切除的指征常受患者年龄的影响。我们旨在评估美国食管腺癌(EAC)手术治疗的利用趋势,并按年龄组进行分层。
我们对2004年至2014年期间美国国立癌症研究所的监测、流行病学和最终结果计划登记处进行了回顾性分析。年龄≥18岁的成年EAC确诊患者符合纳入标准。采用泊松回归计算按年龄组(18 - 49岁、50 - 70岁和>70岁)分层的食管切除术年发病率。使用加权对数二项回归比较各年龄组中接受食管切除术的患者比例。采用治疗权重的逆概率来考虑潜在的混杂因素。
共纳入21301例患者。在研究期间,18至49岁患者的食管切除率从34.1%降至28.2%(P = 0.40),50至70岁患者从38.6%降至33.3%(P = 0.06),70岁以上患者从21.4%降至16.9%(P = 0.04)。在考虑患者和癌症特征后,70岁以上患者接受食管切除术的可能性比18至49岁患者低50%(风险比[RR] 0.51,95%置信区间[CI] 0.45 - 0.57,P < 0.0001),比50至70岁患者低50%(RR 0.53,95% CI 0.50 - 0.56,P < 0.0001)。
在美国,70岁以上患者很少采用手术切除。有必要进一步研究老年患者的手术结果,以确定在大部分EAC患者中手术治疗是否未得到充分利用。